Israel VC Funds

Oxx VC is a venture capital firm specializing in B2B SaaS investments, focusing on scale-up stage companies in Europe and Israel. Founded in 2017, Oxx operates from London and Stockholm, providing essential growth capital and strategic resources to help companies achieve explosive growth. Notable investments by Oxx include Peak, a SaaS company leveraging AI for decision intelligence; Funnel, which offers marketing data hub solutions; and Codility, a platform for technical hiring. These investments highlight Oxx's commitment to supporting innovative software companies that have achieved product-market fit and are ready to scale. Oxx recently closed its second fund at €172 million, backed by institutional investors such as British Patient Capital, Saminvest, KfW Capital, and Argentum. This fund will continue to support SaaS companies through growth stages, particularly those focusing on AI-driven innovations. The firm, led by co-founders Richard Anton and Mikael Johnsson, prides itself on a selective, evidence-based investment approach, providing tailored support to each portfolio company. Oxx's mission is to help build global category leaders in the SaaS sector by combining deep industry knowledge, a strong network, and hands-on partnership.

Panakès Partners, based in Milan, is a leading venture capital firm specializing in life sciences. Founded by Diana Saraceni, who has over 20 years of experience in the VC industry, the firm focuses on early-stage startups and SMEs developing innovative technologies in biotech, diagnostics, and medical devices. Their portfolio includes notable investments like EndoStart and Diadem, reflecting their commitment to groundbreaking solutions in healthcare. Panakès primarily targets Europe and Israel, aiming to address significant unmet medical needs with a robust ESG framework. Their latest €175 million fund, the Purple Fund, emphasizes Series A investments, supporting around 15-18 companies with average checks ranging from €5 to €10 million. Known for leading rounds, Panakès actively engages with startups through a rigorous selection process, valuing sustainability and impactful health solutions. The team, led by Saraceni, brings extensive expertise and a strong network in the life sciences sector, bolstered by their participation in various national and international advisory boards. For entrepreneurs, Panakès is approachable via direct submissions to their email, fostering a transparent and accessible investment process.

Pantera Capital is a pioneering venture capital firm focused exclusively on blockchain and cryptocurrency investments. Founded by Dan Morehead in 2003, Pantera launched the first cryptocurrency fund in the U.S. in 2013 when Bitcoin was valued at $65 per BTC. They have since introduced various funds, including the first blockchain-focused venture fund and the first early-stage token fund in 2017. Pantera manages $5.6 billion in assets, providing investors with comprehensive exposure to the blockchain ecosystem through venture equity, early-stage tokens, and liquid tokens. Their investment strategy is global, having backed over 100 blockchain companies and 110 early-stage token deals across sectors like decentralized finance (DeFi), next-gen payment systems, and institutional trading tools. The firm's notable funds include the Pantera Venture Funds, Pantera Bitcoin Fund, Pantera Liquid Token Fund, and the all-encompassing Pantera Blockchain Fund. Their extensive portfolio features key players in the blockchain space, contributing significantly to the industry's infrastructure and growth. Pantera Capital operates from offices in the Bay Area, New York, and Puerto Rico, with a team of seasoned professionals bringing decades of experience from top-tier financial firms and technical backgrounds.

Paradigm Ventures is a prominent venture capital firm that excels in investing within the cryptocurrency and blockchain technology sectors. Their portfolio boasts notable investments such as Coinbase, Chainalysis, and OpenSea, reflecting their strong presence in the digital assets space. They focus on investing in early-stage ventures but also support companies through various growth stages with investment sizes ranging from $1M to $100M. Paradigm's investment strategy is deeply research-driven, often leading rounds and providing significant hands-on support in areas like technical mechanism design, smart contract security, and operational scaling. This approach not only ensures the technological robustness of their portfolio companies but also aids in achieving long-term growth and market leadership. Geographically, Paradigm is heavily invested in the United States, particularly within major tech hubs such as San Francisco. However, their investments and interest span globally, targeting innovative companies that push the boundaries of blockchain technology. Paradigm prefers to be approached by startups with a clear and compelling vision for their technology and its impact on the crypto ecosystem. They are highly selective, looking for teams with strong technical foundations and a demonstrated ability to execute their vision effectively.

PeakBridge VC is a venture capital firm focused on Agri-FoodTech, investing in companies that address major challenges in the global food system. Founded in 2016 and headquartered in Malta, PeakBridge aims to create long-term impact by investing in startups that drive sustainable solutions, improving both environmental and health outcomes across the food chain. The firm’s investment strategy is centered on five key areas: ingredient innovations, alternative protein technologies, food system digitalization, nutrition & health, and alternative farming systems. By investing in these sectors, PeakBridge helps startups scale solutions that tackle issues such as food waste, nutrition deficiencies, and the carbon footprint of food production. Its portfolio includes innovative companies like Standing Ovation (dairy substitutes through microbial fermentation), Vow (cultured meat), and Rival Foods (plant-based protein). PeakBridge operates through its FoodSparks® Seed Fund for early-stage European and Israeli startups, and Growth II Fund for Series A-B investments in Europe, the U.S., and Israel. The firm’s total assets under management exceed $250 million, with significant backing from Edmond de Rothschild Private Equity. As an Article 9 fund under the Sustainable Finance Disclosure Regulation (SFDR), PeakBridge integrates strict ESG principles into its investments, ensuring all portfolio companies contribute to a healthier and more sustainable food system.

Pereg Ventures is an early-stage cross-border venture capital firm founded in 2012 by Managing Partners Itzhak Fisher and Ziv Ben-Barouch and headquartered in Midtown Manhattan, with deep operational roots in Israel. Venture Partner Mark Leiter complements the founding team, which collectively brings more than three decades of investment and startup operating experience across more than 100 prior investments. The firm invests in disruptive B2B data-driven ventures that accelerate consumer-facing enterprises, with a focus on retail technology, e-commerce, digital marketing, and consumer-behavior analytics. Pereg's core thesis leans on its dual geographic footprint: sourcing raw technological innovation from Israel while providing US market access, distribution, and go-to-market expertise to portfolio companies. The firm leads rounds in seed through Series B stages. Pereg Ventures Fund I closed in February 2015 with anchor support from Nielsen, which provided a significant LP commitment, alongside Tata. The portfolio consists of 18 companies including one unicorn: Bringg, which reached unicorn status in 2021 four years after Pereg's first investment. Additional portfolio companies include Onclusive, RetailNext, Nutrino, CB4, Engage3, Discuss.io, Crosswise, Syte, ChannelEyes, Cielo24, OurCart, Quaero, and Staq. The firm has produced one IPO and six acquisitions. The most recent exit was RetailNext in January 2025, and the most recent new investment was a December 2024 controlling-stake acquisition of AI apparel commerce platform Syte, co-led by Pereg with Magma VC, MizMaa, and Stardom Ventures. Pereg's Israel-US bridge model gives it early access to enterprise data and analytics technology coming out of Israel's deep talent pool in intelligence and cybersecurity, which it then connects to some of the world's largest retail and consumer brands in the United States.

Peregrine Ventures is Israel's first dedicated healthcare-focused venture capital fund, founded in 2001 in Or Yehuda by serial entrepreneur brothers Eyal Lifschitz (Co-Founder and General Managing Partner) and Boaz Lifschitz (Co-Founder and General Partner), who previously co-founded biomedical device companies Visioncare Ophthalmic Technologies and BioControl in the 1990s. The firm today manages approximately $600 million in assets across a multi-fund platform that pairs early-stage venture investing with Peregrine Growth, a $300 million late-stage life-sciences fund launched in November 2020, plus earlier funds including a $115 million med-tech vehicle. Partners Tamir Tal, Lior Shahory, David Eldar, and Shiran Tehila Mashiah complement the founding team. A distinctive feature of the platform is its embedded synergy with the Incentive Incubator, giving portfolio companies deep operating support from the pre-company stage through clinical and commercial scale-up. Peregrine leads rounds and has made approximately 172 investments into around 75 active and realized portfolio companies, with one unicorn, one IPO, and 16 acquisitions to date. Notable outcomes include Insightec, Quicklizard, and Eledon. Startup Nation Central named Peregrine Israel's most active healthtech investor for 2024, based on 15 strategic health-tech deals. The investment scope covers life sciences broadly: healthcare, digital health, medical devices, therapeutic devices, pharma, biotechnology, and medical software. Recent investments include Lutris Pharma ($30 million, January 2025) and Aluma Healthcare in September 2025. Peregrine's 25-year track record in Israeli healthcare and its deeply integrated incubator model create a continuum from scientific concept to clinical validation that few other investors can offer. By maintaining active involvement at every stage from incubation through growth equity, the firm builds durable portfolio relationships that extend well beyond a standard investment horizon.

Phenomen Ventures (Phenomen VC) is a mid-to-late-stage global venture capital firm founded in 2012 and based primarily in London, United Kingdom. The firm describes itself as investing in 'internet and tech phenomenons' — category-leading, fastest-growing companies across the United States, Europe, and Israel. Phenomen focuses on information technology, SaaS, and consumer internet, predominantly at Series A and Series B stages, with particular historical emphasis on Germany-based startups. The firm operates with a lean team of three partners and has more than $300 million in committed capital across 22 investments, with portfolio companies reaching customers in 35 countries. The portfolio carries an enviable track record with two major European consumer-tech IPOs: HelloFresh (listed on Euronext in November 2017 at a $1.91 billion market cap) and Delivery Hero (listed on the Frankfurt Stock Exchange at a $5.01 billion market cap). Four portfolio companies have been acquired in total, including FREE NOW, which was acquired by Lyft for $199 million in April 2025. Other disclosed portfolio companies include Arbox (business and productivity software, most recent investment in September 2025), Constru, Foodpanda, and LightYX. Phenomen Ventures applies a concentrated, conviction-driven approach to identifying category-defining companies at the Series A and B junctures where growth trajectories become apparent but valuations remain constructive. The firm's track record in consumer internet and food technology, combined with its pan-European perspective and US and Israeli deal connectivity, positions it as a specialist partner for founders seeking a globally networked investor with demonstrated success in scaling internet businesses to IPO.

Philips Ventures is the venture capital arm of Royal Philips, focusing on early- to growth-stage investments in healthcare technology startups that align with Philips’ mission to improve patient outcomes, reduce healthcare costs, and transform the healthcare experience. Established in 1998 and based in Amsterdam, Philips Ventures invests globally, supporting companies that develop digital health solutions, medical devices, and health technology services. The fund is business-agnostic but emphasizes sectors like digital software, AI-driven health solutions, and technology-enabled services. Philips Ventures provides not just capital but also strategic support, offering startups access to Philips' extensive clinical and regulatory expertise, global market insights, and deep relationships within the healthcare industry. Their investment strategy includes leading or co-leading rounds, with initial investments typically ranging from $2 million to $5 million, and they actively syndicate deals to collaborate with other investors. Philips Ventures also fosters partnerships between their portfolio companies and Philips' various business units, helping startups scale and navigate the complex healthcare landscape. This approach has led to investments in companies like Elucid, Validic, and MIVI Neuroscience, all of which are pushing the boundaries of healthcare innovation.

Ping An Ventures is the corporate venture capital arm of Ping An Insurance (Group) Company of China, one of China's largest insurance and financial services conglomerates. Founded in 2012 with RMB 1 billion (~$150 million) of seed capital from Ping An Insurance, the firm is headquartered in Pudong, Shanghai and holds the distinction of being the first VC fund launched out of China's financial industry. Ping An Ventures invests across fintech, healthcare, consumer, and technology verticals — spanning domestic and overseas opportunities — with a focus on middle-to-late growth rounds, pre-IPO, and PIPE transactions that align with Ping An's own digital transformation roadmap. The firm has made approximately 160 investments across its history, with check sizes typically ranging from $3 million to $50 million. To extend its global reach, Ping An Ventures launched the Hong Kong-based Global Voyager fund at $1 billion to source healthcare and fintech assets in the United States, Israel, and Singapore, and has targeted up to $1.3 billion across two additional healthcare-focused growth-stage funds. Notable portfolio companies include Didi Chuxing, Meituan-Dianping, Oscar Health, Payoneer, Taulia, Hycor Biomedical, Fabric Genomics, and Tmunity Therapeutics. Recent exits include eToro and Fabric Genomics, acquired by GeneDx for $51 million in April 2025. Ping An Ventures operates with a lean team of eight investment professionals and maintains a disciplined approach to portfolio construction, concentrating on companies where Ping An's insurance, fintech, and healthcare networks create tangible strategic advantage. The firm functions as both a financial investor and a strategic partner, connecting portfolio companies to Ping An's vast distribution ecosystem across China and select global markets.

Pirveli Ventures is a Montreal-based family fund that focuses on early-stage investments, particularly in Israeli startups. The fund is known for its laid-back, hands-on approach, providing both initial and follow-on investments while actively supporting portfolio companies in areas like strategy, business development, and management. This close involvement allows Pirveli to act as an extension of the startup teams they back. Their investments typically center around sectors such as agricultural tech, health tech, sustainability, and automotive technologies. Notable companies in their portfolio include Gordian Surgical, Eco Wave Power, and Flora Fotonica, reflecting a commitment to innovative, high-impact ventures. Pirveli Ventures generally invests in the seed stage, and while they do not limit themselves to a specific check size, they are comfortable co-investing alongside other funds. Their investment philosophy focuses on working with startups that have a clear business plan and strong management teams, helping them transition from innovative ideas to successful companies​.

Pitango Venture Capital, established in 1993 and based in Herzliya, Israel, is one of the largest and most prominent venture capital firms in Israel, managing over $3 billion across various funds. The firm focuses on investing in early-stage startups through Pitango First, growth-stage companies through Pitango Growth, and health tech innovations through Pitango HealthTech. Pitango has backed a range of notable companies that have become leaders in their respective fields. These include Via Transportation, which has revolutionized urban mobility, Taboola, a significant player in content recommendation and discovery, and Varonis Systems, a cybersecurity company. The firm has also been involved in successful exits, such as the acquisition of Anobit by Apple and the IPO of Radware on NASDAQ. The investment strategy of Pitango emphasizes partnering with visionary entrepreneurs and providing them with the necessary resources and guidance to scale their businesses. The team at Pitango includes experienced professionals like Nechemia (Chemi) Peres and Rami Kalish, who bring a wealth of expertise to the firm’s diverse investment portfolio. Pitango's approach is characterized by a strong commitment to innovation and sustainability, ensuring that the companies they invest in are not only successful but also contribute positively to the broader community. This dedication has positioned Pitango as a key player in both the Israeli and global venture capital ecosystems.

Planet A Ventures, based in Berlin, is a pioneering venture capital fund dedicated to supporting GreenTech startups that drive significant environmental impact. With a first fund of €160 million, Planet A invests primarily in European companies focused on achieving net-zero emissions and promoting sustainability across various sectors including agriculture, energy, manufacturing, and transportation. Notable investments include Makersite, which uses AI to enhance sustainable supply chains, and INERATEC, known for its modular chemical plants producing sustainable fuels. The fund also backs innovative solutions like Wildplastic, which recycles plastic waste, and GA Drilling, which develops geothermal energy technologies. Planet A takes a science-based approach to investing, incorporating life cycle assessments into its due diligence process to ensure each investment's positive impact. This methodology allows their in-house science team to veto investments that don't meet stringent environmental criteria. The fund typically writes initial checks ranging from €500k to €3 million and prefers to lead rounds. Key team members include founders Tobias Seikel, Nick de la Forge, Fridtjof Detzner, Christian Schad, Christoph Gras, and Lena Thiede. Their combined expertise spans investing, entrepreneurship, and environmental science, ensuring a well-rounded support system for portfolio companies. Active engagement with portfolio startups and a commitment to scalable, impactful solutions position Planet A Ventures as a leader in the GreenTech VC space.

Planeteer Capital is a venture capital firm based in New York City that focuses on pre-seed and seed-stage investments in climate tech startups. Founded by Sophie Purdom, a co-founder of Climate Tech VC (CTVC), Planeteer Capital aims to partner with founders who are addressing the challenges of climate change through innovative technologies and solutions. The firm is anchored by an Ivy League endowment and backed by notable investors including Collaborative Fund and former Meta CTO Mike Schroepfer. Planeteer Capital targets sectors such as carbon management, industrial decarbonization, the built environment, climate intelligence and insurance, and sustainable agriculture. The firm’s mission is to empower visionary founders with the necessary capital and network to prove and scale their transformative models. Planeteer Capital distinguishes itself by providing not just financial support, but also strategic guidance and a sophisticated understanding of the climate tech capital stack​​.

Pontifax Venture Capital is a healthcare-focused venture capital firm based in Herzliya, Israel, founded in 2004. The firm manages approximately $1.2 billion across multiple funds and focuses on identifying and investing in transformative life sciences technologies at all stages of development. Pontifax's portfolio includes around 100 companies that address significant unmet medical needs through groundbreaking innovations​. The firm was co-founded by Eli Hurvitz, a legendary figure in the pharmaceutical industry and former CEO of Teva Pharmaceuticals, alongside Ran Nussbaum and Tomer Kariv. Pontifax takes a hands-on approach with its portfolio companies, providing strategic guidance and leveraging extensive networks to help these companies grow and succeed. Pontifax's investment strategy spans various sectors within the life sciences, including biopharmaceuticals, medical devices, and gene therapy. Notable investments include Kite Pharma, which was acquired by Gilead Sciences, and Eloxx Pharmaceuticals, which focuses on treatments for genetic diseases caused by nonsense mutations.

Porsche Ventures is the global corporate venture capital arm of Porsche AG, the Stuttgart-based German luxury sports car manufacturer. Established in 2016, the unit has grown into a systematic startup ecosystem with employees across five international hubs: Luxembourg (legal domicile), Berlin, Palo Alto, Tel Aviv, and Shanghai. The firm is led by Managing Director Ulrich Thiem under the strategic oversight of Lutz Meschke, Deputy Chairman of Porsche AG's Executive Board for Finance and IT. Porsche Ventures operates under a strategy organized around four investment fields: Car and Mobility, Intelligent Enterprise, Sustainability, and Beyond — the last encompassing AI, blockchain, VR/AR, and Web3. The firm maintains an annual investment framework of approximately EUR 150 million and has earmarked up to EUR 250 million for new investments and follow-on tickets. Cumulatively, Porsche has invested approximately EUR 300 million into 52 current portfolio companies, with 72 total disclosed investments, 4 unicorns, 2 IPOs, and 5 acquisitions. Notable portfolio companies include Rimac Automobili (in which Porsche holds a 22% stake via the Bugatti Rimac joint venture), Cresta, Nozomi Networks, TriEye, Anagog, Urgent.ly, WayRay, VAHA, Via, and ZEDEDA (participating in its $72 million Series C). Porsche Ventures functions as both a financial investor and a strategic accelerator: portfolio companies gain access to Porsche's global customer base, engineering expertise, manufacturing know-how, and retail distribution network. The firm's five-hub model ensures deal sourcing proximity to the world's most active technology ecosystems, while its industry focus on mobility and intelligent enterprise keeps the portfolio closely aligned with Porsche AG's own long-term innovation roadmap.

Presight Capital, founded in 2019 by Christian Angermayer in partnership with Apeiron Investment Group, is a global venture capital firm based in West Hollywood, California. The firm manages over $600 million in assets across two early-stage funds and focuses on investing in biotechnology, consumer, fintech, deep tech, food tech, cryptocurrency, healthcare, and technology sectors. Notable investments by Presight Capital include ATAI Life Sciences, a mental health company using psychedelics; AbCellera, a biotech firm specializing in antibody therapies; and Compass Pathways, which focuses on mental health treatments using psilocybin. Other prominent companies in their portfolio are General Fusion, EnergyVault, and Perfect Day, which produces lab-grown dairy products. Presight Capital aims to support ambitious founders by providing capital, connections, and strategic advice. They invest in various stages, from seed to IPO, and have a diverse portfolio that includes companies like Razor Group, Syfe, and Alto Neuroscience. The firm's approach is characterized by a strong emphasis on transformative technologies and groundbreaking solutions across different industries​.

Previz Ventures is a tech and life sciences-focused early-stage venture capital firm founded in 2011 and headquartered in Herzliya, Israel. The firm invests into innovative technology companies addressing critical challenges in medical devices and healthcare information and communications technology, with a clearly defined entry point at post proof-of-concept, initial-to-approaching-commercial stage companies targeting large, underserved markets with scalable solutions. Previz concentrates overwhelmingly on Israeli-based companies to leverage the density of deep-tech talent in the Israeli ecosystem and the unique market access of its management team. The firm is led by founder and Managing Director Eliav Azulay Oz and operates with a small three-person team consistent with its selective, concentrated portfolio strategy. Previz has made approximately 8 disclosed investments and has a strong exit track record relative to its size. ReWalk Robotics (formerly Argo Medical) — a powered exoskeleton enabling paralyzed individuals to walk, stand, sit, and climb stairs — completed a NASDAQ IPO in September 2014 at an approximately $136 million market cap. Orpheus Medical, an enterprise clinical-video imaging platform, was acquired by Intuitive Surgical in February 2020. Clear-Cut Medical (intra-operative compact MRI for margin assessment of cancerous tissue) was among the firm's later disclosed investments. Previz screens investment candidates not only for financial return potential but for the transformative social value they can create in healthcare — improving patient outcomes, quality of life, and access to care. This dual mandate shapes the firm's portfolio construction: each company must meet a high bar on both clinical significance and commercial scalability. The firm provides ongoing strategic guidance across the full investment life cycle, from initial product development through regulatory clearance and downstream financing.

BBVA has a strong presence in the venture capital space through its BBVA Spark and Propel Venture Partners. BBVA Spark, launched in 2023, is focused on supporting high-growth companies, offering a range of financial products and services tailored to the needs of startups and scaleups. BBVA Spark integrates the bank’s Open Innovation initiatives to foster connections within the entrepreneurial ecosystem, facilitating collaborations between startups and established companies. Since its inception, BBVA Spark has invested €200 million in venture capital funds and provided over €100 million in financing across Spain and Mexico, supporting nearly 500 companies. Propel Venture Partners, established in 2016, is another key component of BBVA's venture capital strategy. Propel focuses on fintech and insurtech investments, with notable portfolio companies like Coinbase, Hippo, and Neon. BBVA has committed over $400 million to Propel, which helps bridge the gap between innovative fintech startups and growth opportunities in the Americas and beyond​.

PsyMed Ventures is a venture capital firm focused on transforming mental health treatment through innovative technologies, particularly in the areas of psychedelic medicine, neurotechnology, and precision psychiatry. Founded in 2020 by Dina Burkitbayeva, Greg Kubin, and Matias Serebrinsky, PsyMed Ventures began as a syndicate and has since evolved into a dedicated venture fund. In 2022, the firm launched a $25 million fund aimed at supporting early-stage startups that are pioneering new approaches to mental health. The fund's investments span a range of groundbreaking companies, including Freedom Biosciences and Delix Therapeutics, both of which are exploring the therapeutic potential of psychedelics. PsyMed's portfolio also includes companies working on advanced digital health platforms, novel drug formulations, and innovative neurotechnologies. PsyMed Ventures is particularly interested in companies at the pre-seed, seed, and Series A stages, believing that these early phases are where they can make the most significant impact. The firm emphasizes the importance of aligning with values-driven investors and entrepreneurs, recognizing that the mental health space requires long-term commitment and a collaborative approach.

Purple Orange Ventures (POV) is a Berlin-based, entrepreneur-led impact seed fund founded in 2012 by Gary Lin. Focused on leveraging science and technology, the fund is dedicated to solving some of the world’s most pressing challenges, specifically aiming to remove animals from the global food system and ensure sustainable food production. POV targets early-stage startups that are pioneering food-tech, agri-tech, and biotech innovations across the globe. POV invests primarily in pre-seed, seed, and Series A stages, with typical investments ranging from €100K to €1.5M. The fund backs mission-driven founders developing technologies in areas such as plant-based foods, lab-grown meat, and sustainable agriculture. Its portfolio includes companies like BLUU Seafood (lab-grown fish), Omni (plant-based pet food), and Change Foods (animal-free dairy). These startups are transforming the food industry by offering sustainable alternatives to traditional animal products. In addition to financial backing, Purple Orange Ventures provides its portfolio companies with business development support, operational expertise, and access to a network of industry experts to help accelerate growth and achieve market leadership. The firm’s mission reflects its commitment to creating a more sustainable, animal-free food ecosystem, positioning itself as a leader in the alternative protein and food technology sectors.

Q Venture Partners is a venture capital firm established in 2016, headquartered in Hong Kong. The firm specializes in early-stage investments, particularly focusing on industries like consumer electronics, Internet of Things (IoT), artificial intelligence, and healthcare technologies. Q Venture Partners has a global outlook, investing primarily in North American and Asian markets, with a particular emphasis on scalable technologies that have the potential to transform industries. Led by co-founders Henry Tan and Larry Tsai, the firm adopts a hands-on approach, providing strategic guidance and support to its portfolio companies. The firm's investment strategy is focused on sectors where technology can create significant value, driving both innovation and market disruption. Notable investments include companies like StrongArm Tech, AREVO, and Preteckt, which are leaders in their respective fields of wearable technology, advanced manufacturing, and predictive maintenance software. Q Venture Partners is actively seeking new investments and typically participates in Series A and B funding rounds, often collaborating with other leading venture capital firms. The firm has a track record of successful exits, including the merger of AREVO in 2024, reflecting its ability to identify and nurture high-potential startups into market leaders.

QB1 Ventures is a New York-based venture capital firm founded in 2015 as the venture arm of Talpion Fund Management, the multi-asset family office led by Alex Swieca. The firm invests in US- and Israel-based technology companies across enterprise software, fintech, sports technology, consumer technology, and healthtech, seeking startups with scalable core technology that solves a genuine problem in a simplified way. Alex Swieca serves as Founder and Managing Partner, with Kevin Swieca as Venture Partner. QB1 targets Seed and Series A rounds with typical check sizes of $100,000 to $1 million and a sweet spot around $250,000, running a deliberately concentrated portfolio of roughly 10 companies rather than a high-volume fund. Named portfolio companies include WSC Sports (AI-powered sports highlight generation), Yellowdig (community learning platforms), Fan AI (sports fan data analytics), GameCo (skill-based gaming), mPrest (power-grid software), Percepto (industrial autonomous drones), ElMindA (brain analytics), Privasea (fully homomorphic encryption for privacy-preserving AI), and Replay Technologies, which was acquired by Intel. The most recent publicly documented exit was RecoverX, acquired by Hyperice in January 2021. The concentration of the portfolio is a deliberate strategic choice: QB1 prioritizes active engagement with each company over breadth of coverage, working closely with founders on strategy, network access, and follow-on fundraising. The firm's dual US-Israel mandate reflects the family office's existing ties to both markets and its view that Israeli deep technology and US market distribution create a natural and complementary investment pairing.

Qiming Venture Partners USA, launched in 2017, focuses on early-stage investments in healthcare, particularly therapeutics and healthcare technologies, across the U.S. and Europe. Backed by its China-based parent firm Qiming Venture Partners, the U.S. arm leverages both financial and human capital to support transformative innovations in healthcare, including drug development and digital health solutions. With over $550 million raised across three funds, Qiming USA has already invested in more than 30 companies and achieved notable exits through M&A and IPOs. Their strategy is centered on partnering with visionary healthcare entrepreneurs, offering not just capital but also deep technical expertise and a global network, including synergies with the broader Qiming platform in China. Key team members include managing partners like Mark McDade and the recent addition of Isaac Ciechanover, whose extensive background in biotech strengthens Qiming’s healthcare focus. Their third fund, closed at $260 million in 2022, continues to invest in innovative therapeutics and health tech ventures that have the potential to make a significant impact on patient outcomes​.

Qualcomm Ventures, founded in 2000, is the corporate venture capital arm of Qualcomm Incorporated, headquartered in San Diego, California. The firm focuses on investing in early to growth-stage companies in sectors such as artificial intelligence (AI), automotive, mobile, enterprise and cloud, and smart systems. It supports startups with strategic guidance, leveraging Qualcomm’s extensive technological expertise and global network. Notable investments from Qualcomm Ventures include companies like Cloudflare, Xiaomi, Zoom, and SentinelOne. These companies have achieved significant milestones, including successful IPOs and high-profile acquisitions. For instance, SentinelOne went public in June 2021, and Zoom became a key player in cloud video conferencing and communication services. Qualcomm Ventures manages over $2 billion in assets and has a portfolio of more than 360 companies, with 22 unicorns and 19 companies that have gone public. The firm is also active in fostering innovation through specific funds like the Qualcomm Ventures AI Fund and the 5G Ecosystem Fund, which target emerging technologies in AI, machine learning, and 5G solutions. The investment team is composed of experienced professionals located in various global regions, including the US, China, and Israel, ensuring a broad and strategic reach to identify and support high-potential startups worldwide​.

Quantonation is a pioneering venture capital fund focused on early-stage investments in quantum technologies and deep physics. Founded in 2018, the Paris-based fund is dedicated to supporting startups working in quantum computing, quantum communications, quantum sensing, and related fields, aiming to accelerate the commercial adoption of groundbreaking scientific innovations. With over €91 million raised in its first fund, Quantonation has backed more than 30 companies, including notable names like Pasqal, ORCA Computing, and Qubit Pharmaceuticals. The fund's strategy targets startups at the pre-seed and seed stages, emphasizing those with the potential to transition quantum innovations into practical, industry-ready applications. These companies address critical areas such as molecular design, high-performance computing, and cybersecurity, with broader impacts expected in fields like healthcare, energy, and climate change mitigation. Quantonation leverages its deep scientific expertise and global network of research institutions, including partnerships with MIT, Ecole Polytechnique, and Oxford University. Quantonation has recently launched its second fund, Quantonation II, with a target of €200 million, signaling its commitment to expanding its support for quantum startups worldwide. Led by a team of experienced scientists and investors like Christophe Jurczak and Olivier Tonneau, the firm is actively shaping the future of the quantum tech ecosystem.

Qure Ventures is Israel's first venture capital fund dedicated exclusively to digital health, founded in 2012 and headquartered in Herzliya. In November 2016 the firm launched a flagship $50 million vehicle in partnership with equity crowdfunding platform OurCrowd, sometimes branded as OurCrowd Qure. The fund invests predominantly in Israel-based digital health startups across Seed, Series A, and selective Series C follow-ons, with an explicit thesis to fund deep-tech solutions that improve patient care, reduce healthcare delivery costs, create data transparency, and empower health consumers. The fund is led by Managing Partners Dr. Yossi Bahagon — founder and CEO of Luminox Health, acquired by OurCrowd, and a recognized digital health expert — and Allen Kamer, co-founder of Humedica, which was acquired by UnitedHealth Group in 2013. Across 12 portfolio companies, notable names include Tyto Care (remote clinical exam kit), DarioHealth (IPO), Zebra Medical Vision (acquired by Nanox), and Carevive, which was acquired by Health Catalyst in June 2024. The portfolio has produced one IPO and three acquisitions in total. Qure's defining operating philosophy is hands-on engagement: roughly 70 percent of team time is devoted to supporting portfolio companies on strategy, business development, growth, and follow-on fundraising. Strategic partnerships spanning consumer, provider, payer, and pharma channels help portfolio companies access clinical-trial pipelines and commercial distribution faster than they could independently. This partnership-intensive model, combined with deep domain expertise in Israeli health technology, positions Qure as a category specialist in one of the world's leading digital health ecosystems.

Radian Capital is a growth equity firm founded in 2016, based in New York City. Specializing in business-to-business (B2B) software and technology-enabled services, Radian focuses on helping companies scale by leveraging advanced sales, marketing, and operational techniques. They typically make investments ranging from $5 million to $30 million, targeting businesses with proven models that are poised for rapid growth. Radian's investment strategy centers around accelerating expansion-stage companies, often stepping in to support businesses that already generate significant revenue. Notable portfolio companies include MURAL, a visual collaboration platform, GreyNoise, a cybersecurity intelligence firm, and Niche, a school search platform. These investments reflect Radian’s emphasis on data-driven and tech-enabled industries. The firm recently closed a $500 million third fund, underscoring its increasing presence in the growth equity space. Radian typically looks for companies with innovative, scalable business models and seeks to partner closely with founders. They focus primarily on the U.S. market but are open to international opportunities. Co-founders Jordan Bettman and Weston Gaddy lead the firm, bringing extensive experience in venture and private equity. The team prides itself on being highly involved with their portfolio companies, providing more than just capital by offering strategic guidance to drive significant long-term value. Startups interested in partnering with Radian are encouraged to demonstrate strong market fit, robust unit economics, and a clear path to scaling​.

Radiant Venture Capital, operating as Radiant Tech Ventures, is a Hong Kong-based technology-focused venture capital firm founded in 2014. The firm manages the Radiant Tech Ventures Fund LP through RTV GP I Limited and is licensed by the Securities and Futures Commission of Hong Kong for Type 9 asset management activities. In August 2018, Radiant was selected as a Co-investment Partner of the Hong Kong government's Innovation and Technology Venture Fund (ITVF Corporation), reinforcing its position as a preferred conduit for deploying public-sector venture capital alongside private limited partners. Radiant is led by Founding Managing Partner Gordon Yen, an SFC Responsible Officer with more than 25 years of operational and board-level experience in technology investing dating to the late 1990s. Venture Partner Hugh Chow — former CEO of Hong Kong Applied Science and Technology Research Institute and co-founder of Pool Global Partners — contributes 30-plus years of global executive experience. The firm's cross-regional network spans Hong Kong, mainland China, Israel, North America, and Southeast Asia, positioning Radiant as a bridge investor for global startups entering Greater China and vice versa. Across 33 investments, the firm has backed Hex Trust (digital asset custodian), Zeek (Southeast Asia logistics), CARFIT, VocalZoom, Zhimadi, and FundPark. Five portfolio exits include Corephotonics (acquired by Samsung) and Pebbles Interfaces (acquired by Facebook's Oculus division). Radiant invests primarily at seed and early stage across fintech, healthtech, AI, consumer technology, and automotive technology. The firm's ITVF partnership and cross-border network give portfolio companies meaningful pathways into the Greater China market alongside capital and strategic guidance.

Radicle Growth, now operating as Clay Capital, is a venture capital firm focused on early-stage investments in agriculture and food technologies. Founded in San Diego, California, Radicle Growth aims to identify and support innovative entrepreneurs and technologies that can transform the food system. They frequently collaborate with global industry leaders to host challenges that fund groundbreaking agtech and foodtech startups. Notable investments by Radicle Growth include MycoTechnology, BlueNalu, Pluton Biosciences, and Phospholutions. MycoTechnology, a pioneer in fungal fermentation, won the $1 million growth-stage investment in the Radicle Protein Challenge by Syngenta. BlueNalu, focused on cell-based seafood, secured a $250,000 early-stage investment in the same challenge. Pluton Biosciences and Phospholutions were the winners of the Radicle Carbon & Soil Challenge by UPL, receiving $1 million and $250,000 respectively, to advance their innovative solutions in carbon sequestration and sustainable phosphorus use. Radicle Growth’s strategy involves not only funding but also providing startups with access to their extensive network of agriculture experts and global connections to accelerate development and promote their technologies. The firm’s commitment to sustainable agriculture is reflected in its continuous efforts to drive innovation and support the development of climate-positive solutions in the food value chain.

Rainfall Ventures is a founder-focused venture capital firm with a strong presence in New York and Los Angeles. Founded in 2011, the firm emphasizes partnering with innovative and passionate founders to help them transform industries. Rainfall Ventures typically invests in early-stage companies, including pre-seed, seed, and Series A rounds, with investment sizes ranging from $1 million to $5 million​. The firm focuses on a broad range of sectors such as analytics, AI, cloud infrastructure, social media, cryptocurrency, cybersecurity, developer tools, digital health, education, fintech, gaming, IoT, and more. This diverse investment strategy allows Rainfall to support a variety of technological advancements and innovative business models. Rainfall Ventures has a portfolio that includes notable companies like Kyra and Blloc, and they invest globally with a particular focus on the US and the UK. The firm has built a reputation for not only providing capital but also offering extensive support to their portfolio companies through mentorship and strategic guidance. The team at Rainfall Ventures includes experienced professionals like co-founder and General Partner Ron Rofé, who bring a wealth of knowledge and expertise to their investment strategy.

Raiven Capital is a global venture capital firm that focuses on early-stage investments, primarily in the areas of Artificial Intelligence (AI), Internet of Things (IoT), and other digital technologies. Founded in 2018, the firm operates with a cross-border strategy, connecting ecosystems between North America, Europe, the Middle East, and Asia. With headquarters in Toronto and additional offices in Palo Alto, Dubai, and London, Raiven Capital seeks to support scalable startups that are leveraging technology to drive significant efficiencies and transformations across various industries. Raiven Capital is known for its hands-on approach, working closely with portfolio companies to help them achieve rapid growth. The firm invests in pre-Series A and Series A companies, providing not just capital, but also strategic guidance, market insights, and access to an extensive global network of industry experts and potential partners. In addition to financial backing, Raiven Capital is deeply involved in the operational aspects of its portfolio companies, helping them navigate challenges and capitalize on opportunities. This approach is aligned with the firm's broader mission to foster innovation that leads to meaningful societal impact, particularly through the deployment of AI and IoT technologies.

Random Forest VC is a boutique early-stage venture capital fund founded in 2018 and headquartered in Tel Aviv, Israel, focused exclusively on market-disruptive ventures built on artificial intelligence and machine learning technologies. The fund backs Israeli and Israeli-linked companies pursuing AI, machine learning, big data, and automation of human-labor workflows across 15 total investments to date. The fund was co-founded by Zeevi Bregman, Gideon Bar Sinai, and Michael Kerbis, each of whom served as pioneering executives at organizations where machine learning was central to their success. Random Forest writes checks typically between $300,000 and $700,000 with effective follow-on capacity up to approximately $1 million, investing from idea stage through seed with selective Series A participation. The fund maintains a follow-on ratio of approximately 1.25. An in-house algorithm team evaluates deep technical claims and supports portfolio companies post-investment — a meaningful differentiation from generalist funds that lack the internal technical depth to assess early-stage AI architectures. Notable recent portfolio investments include QbiqAI (generative AI for real-estate layout design, which raised a $10 million Seed in September 2023 and a $16 million Series A in January 2025), Quai MD ($3 million pre-seed in July 2024; AI clinical best-practices platform), Eyecuracy ($1.3 million Seed in January 2024; AI-powered eye tracking), and FeelBetter ($5.9 million SAFE in July 2023; polypharmacy patient management). The broader team of co-founders and investment partners actively mentors portfolio companies alongside capital deployment, bringing hands-on domain expertise in machine learning systems. Random Forest's narrow vertical focus and technical evaluation capability give it conviction in deals that broader funds may struggle to underwrite accurately.

Recursive Ventures is a venture capital firm based in San Francisco, focusing on pre-seed and seed investments in tech startups that leverage data and artificial intelligence. Founded by Itamar Novick, Recursive Ventures is known for its nimble and founder-friendly approach, offering strategic guidance and operational support alongside capital. The firm typically invests between $300K and $500K initially, with the capacity to invest up to $1.5M over the lifetime of a company. Recursive Ventures has a diverse portfolio that includes companies across various sectors such as fintech, SaaS, AI, proptech, and insurance tech. Notable companies in their portfolio include DataJoy, Armory, and Life360, with several successful exits and IPOs highlighting their investment success. Recursive Ventures distinguishes itself by moving quickly and making decisions in days rather than weeks, ensuring minimal disruption to founders. They focus on helping startups secure subsequent funding rounds and leverage a vast network of top VC firms globally to support their portfolio companies.

Red Dot Capital Partners, established in 2016 and based in Savyon, Israel, is a growth-stage venture capital firm that focuses on Israeli technology startups. The fund typically invests in companies that have achieved product-market fit, particularly at late Series A to Series C stages, with check sizes ranging from $10 to $20 million. Red Dot is known for leading rounds and plays an active role in guiding portfolio companies through global expansion, particularly into South East Asia and Japan. Their sector-agnostic approach allows them to support companies across various industries, with notable investments in Global-e (cross-border eCommerce), Armis (IoT security), and Granulate (performance optimization). The firm emphasizes working closely with founders, often taking board seats to provide hands-on operational and strategic support throughout the startup's growth journey. Led by co-founders Yaniv Stern and Yoram Oron, Red Dot's team brings decades of experience in venture capital, tech, and global market expansion. They prioritize helping Israeli companies scale internationally, leveraging their network to drive success in new markets.

Redline Capital Management, founded in 2014 and headquartered in London, is a global venture capital and growth equity firm. The firm invests in fast-growing companies with differentiated technologies across North America, Europe, and Israel. Redline's investment focus includes sectors such as security and data, enterprise software, internet and cloud, fintech and e-commerce, AI and robotics, and life science technologies. Redline supports companies through all stages of their development, offering strategic guidance and leveraging their extensive industry experience. Some notable investments include Prosimo, Balbix, and Voltron Data. The firm has successfully exited from several companies, including ZeroFOX, Innovium, and Si-Bone, demonstrating a strong track record in scaling and realizing value from their portfolio companies. The leadership team at Redline Capital includes CEO Tatiana Evtushenkova and Managing Directors such as Dmytro Zakurnaiev and Alastair Cookson. They have built a robust portfolio and continue to back strong management teams driving innovation and growth in their respective sectors.

REV Venture Partners, founded in 2000 and based in London, is a venture capital firm that invests in early-stage technology companies. Backed by RELX Group, a global provider of information-based analytics and decision tools, REV focuses on sectors such as big data, analytics, healthcare information, software, mobile platforms, and internet technologies. Notable investments by REV Venture Partners include companies like Palantir Technologies, a leader in data analytics which went public on the NYSE; EdCast, an AI-powered knowledge cloud for personalized learning, acquired by Cornerstone; and Signal Media, an AI company specializing in media monitoring and business intelligence. Other significant investments include Agworld, a global platform for farm management, and CreativeLive, an educational platform acquired by Fiverr. The firm has a strong track record of successful exits. For example, they have seen acquisitions of companies like iPhrase by IBM, Siperian by Informatica, and Business.com by RH Donnelly. REV continues to leverage its extensive network and deep industry expertise to support portfolio companies in transforming their respective markets through innovative data and technology applications. Led by experienced professionals such as co-founding partners Tony Askew and Kevin Brown, REV Venture Partners maintains a collaborative and hands-on approach to venture investing, providing strategic support and resources to foster growth and success in the companies they back.

Regeneration.VC is an early-stage venture capital firm based in Los Angeles, focused on supercharging consumer-powered climate innovation. Founded in 2020, the firm targets companies that drive sustainability through circular and regenerative business models. Regeneration.VC invests in businesses across three core themes: Design, Use, and Reuse, aiming to redefine how products are created, utilized, and recycled. The firm’s investment strategy emphasizes companies that offer innovative solutions to pressing environmental challenges, particularly in sectors like next-gen materials, sustainable fashion, food and beverage, and reverse logistics. Regeneration.VC uses a rigorous multi-factor system to assess the circular and regenerative potential of potential investments, ensuring that their portfolio companies contribute meaningfully to the reduction of waste and carbon emissions. Regeneration.VC is supported by a diverse team of industry veterans, entrepreneurs, and impact investors, including high-profile figures like Leonardo DiCaprio, who actively contribute to the firm’s mission. This expertise allows the firm to provide more than just capital; they offer strategic guidance, networking opportunities, and operational support to help portfolio companies scale effectively and sustainably. The firm’s portfolio includes innovative companies like Cruz Foam, which produces compostable alternatives to polystyrene, and Greyparrot, an AI-powered waste management platform. With a growing fund and a strong commitment to driving positive environmental impact, Regeneration.VC is at the forefront of the consumer ClimateTech movement, helping to build a more sustainable and circular economy.

Remagine Ventures is an early-stage venture capital firm founded in 2018 and headquartered in Tel Aviv, Israel, with a London presence. The firm provides first-institutional pre-seed and seed checks to Israeli founders building at the intersection of technology, entertainment, data, and commerce — now sharply positioned around AI infrastructure, AI agents, and consumer and enterprise applications in the AI-powered digital economy. The firm is led by co-founders Eze Vidra, formerly General Partner at Google Ventures, and Kevin Baxpehler, previously head of venture capital at ProSiebenSat.1 Media SE, with Michael Lewkovicz as non-managing partner. Remagine raised Fund I at approximately $35 million to $40 million and closed Fund II at $25 million in November 2025, explicitly structured around three pillars: AI infrastructure, AI agents, and AI applications delivering measurable business or consumer outcomes. LPs include major European media companies and strategic investors from North America, Europe, and Asia. Remagine leads rounds and has made 41 total investments across gaming, media and entertainment, enterprise applications, consumer, and AI sectors. Several portfolio companies have attracted follow-on capital from Andreessen Horowitz, General Catalyst, and Insight Partners. Notable names include Troup AI, Keewano (gaming analytics agent), Bridge (post-sales automation), and Somalogic, which was acquired by Illumina for $425 million in June 2025. Remagine explicitly does not invest in healthcare, cybersecurity, or defense, allowing the team to develop deep domain expertise in AI-driven entertainment, commerce, and productivity applications. The combination of Vidra's Google Ventures background and Baxpehler's media industry relationships provides a differentiated LP and portfolio company network that spans Silicon Valley, European broadcasters, and Israeli deeptech.

Repsol, a global multi-energy company based in Spain, operates a robust venture capital arm focused on advancing the energy transition through strategic investments in innovative technologies. Their venture capital activities are primarily managed through two funds: Repsol Deep Tech and SC Net Zero Ventures. Repsol Deep Tech is an evolution of the company's earlier corporate venturing efforts. With an allocation of €50 million, this fund focuses on early-stage startups developing breakthrough technologies in areas such as decarbonization, advanced mobility, and renewable energy. Repsol Deep Tech offers startups not only financial support but also access to Repsol's vast industry expertise and testing facilities at the Repsol Technology Lab. This fund targets technologies that are in the initial development stages but have high potential to contribute to the global energy transition. Complementing this is SC Net Zero Ventures, a €150 million fund launched in collaboration with Suma Capital. This fund focuses on more mature startups, aiming to scale technologies that can accelerate the decarbonization of industries, enhance low-carbon mobility, and expand renewable energy solutions. SC Net Zero Ventures is international in scope, investing primarily in Europe and North America. It combines Repsol's deep knowledge of energy transition technologies with Suma Capital's experience in ESG and sustainable investments, making it a key player in the global push towards a low-carbon economy. Through these initiatives, Repsol is positioning itself as a leader in the energy transition, leveraging its financial resources and technological expertise to drive significant advancements in sustainable energy.

Rerail is a London-based solo-GP micro-fund founded in 2024 by Anthony Danon, a decade-experienced fintech investor who began his career at Anthemis Group in 2014 — where he worked on TrueLayer's seed round — before becoming Partner at Speedinvest, where he backed Primer and Wayflyer. Danon subsequently co-founded Cocoa with Carmen Alfonso Rico in 2021, completing 35 investments before the pair amicably parted ways to raise separate successor vehicles. Rerail One hit a first close at roughly $20.5 million against a $20 million to $25 million target in October 2024, backed predominantly by founders and operators as LPs. Rerail writes checks of $200,000 to $500,000 at pre-seed and seed stages in collaborative rounds — not solo-leading. The firm's philosophy treats fintech as a horizontal infrastructure layer rather than a narrow vertical: the mandate extends beyond pure financial services into fintech-enabled healthcare, energy, logistics, supply chain, property, and vertical AI, with a deliberately global rather than Europe-only footprint. Publicly documented portfolio companies include uiAgent (AI agent platform for accounting firms, which raised a $4.6 million seed in September 2025), Spiko (financial software), and Apprentice AI (co-invested alongside Maple Capital, Pitango Venture Capital, and Vertex Ventures Israel). As a newly launched fund with fewer than four public investments, Rerail is in early portfolio construction. Danon's prior track record across Anthemis, Speedinvest, and Cocoa covers more than 35 deals and establishes a credible pre-fund history. The operator-backed LP base signals alignment between the fund's investors and the founder communities it targets, a structure increasingly favored by first-time managers seeking to build deal flow through relationship density.

Rethink Capital Partners is an impact-focused investment firm that manages a diverse array of strategies aimed at generating both financial returns and positive social and environmental impact. As part of Seavest Investment Group, Rethink Capital Partners oversees several funds, including Rethink Education, Rethink Food, and Rethink Impact, each targeting different sectors. Founded with the mission of leveraging capital to drive systemic change, Rethink Capital Partners has invested in various sectors including education technology, food technology, and gender equity. The firm has a strong emphasis on diversity, with a significant portion of its investments in women-led and minority-led companies. They are pioneers in impact investing, often ahead of market trends, and focus on businesses that address critical societal challenges. Notable additions to their team include Amy Nelson, Chief Strategy Officer, and Alison Smith, Partner, who bring substantial expertise and networks to the firm. Their roles focus on growing Rethink’s strategies and expanding their impact.

RELX is a global provider of data-driven analytics and decision tools across diverse industries such as science, law, healthcare, and business. With headquarters in London, RELX operates in over 40 countries, serving millions of professionals worldwide through subsidiaries like Elsevier, LexisNexis, and Reed Exhibitions. These platforms offer critical insights, from scientific research and legal frameworks to business intelligence, aiding decision-making for customers in more than 180 countries​. In addition to its core services, RELX has a venture capital arm called REV, which invests in early-stage companies that are reshaping industries through innovative uses of data and technology. Since its founding in 2000, REV has allocated over $250 million across a range of sectors, particularly artificial intelligence, data science, and healthcare technology. The firm’s portfolio boasts numerous successful exits, including Palantir’s IPO and acquisitions by leading firms such as HealthQuest Capital, Edifecs, and IBM. REV’s mission is to foster companies that can scale transformative technologies globally, helping to solve complex problems in areas such as healthcare, legal tech, and digital content management​. Through these investments, RELX combines its expertise in data analytics with a strategic approach to innovation, enabling it to remain at the forefront of digital transformation across industries. This dual focus on operational excellence and forward-thinking investments positions RELX as a key player in both traditional and emerging markets.

Right Side Capital Management (RSCM), based in San Francisco, is a venture capital firm specializing in pre-seed stage investments in technology startups. Since its inception in 2010, RSCM has focused exclusively on pre-seed funding, making it their primary investment stage. They have an extensive portfolio with over 1,000 investments, showcasing their commitment to early-stage ventures​. RSCM's investment strategy is systematic and data-driven, targeting startups across various tech sectors, including SaaS, AI, and biotech. They typically invest between $100K and $300K per company, with total round sizes ranging from $100K to $500K. The firm prefers startups that have achieved some traction, usually generating $5K to $30K in monthly gross profit​. Notable investments by RSCM include DigitalOcean, ClassPass, and Upsie, reflecting their success in identifying high-potential startups early on. They have a strong track record, with 201 exits from their portfolio, highlighting their effectiveness in supporting startups to successful outcomes​. The leadership team at RSCM includes Managing Directors Dave Lambert, Kevin Dick, and Jeff Pomeranz, each bringing a wealth of experience in entrepreneurship, technology management, and private equity. This experienced team focuses on providing hands-on support and quick investment decisions, ensuring a founder-friendly approach​​. RSCM's geographic focus primarily includes the United States and Canada, with occasional investments in Western Europe, Israel, Australia, and New Zealand. Their investment philosophy emphasizes capital-efficient business models that can achieve significant returns even with smaller exit values​.

Rimonim Venture Capital -- also branded Rimonim Agro Fund -- is an Israeli specialist venture capital firm founded in 2017 and headquartered in Kefar Vitkin, Israel. The firm invests exclusively in Israel's agri-tech and food-tech ecosystem, with a declared mission to address the global food-shortage challenge by backing internationally scalable Israeli agricultural technology companies at early and mid-stage. Co-Founder and Partner Sharon Devir, a Technion alumnus, is a public face of the firm, including through appearances at Global AgInvesting. The investment mandate spans six core verticals: agricultural biotechnology, farm robotics and mechanization, supply chain technologies, novel farming systems, farm management software and IoT, and innovative food. Rimonim Agro Fund I began investing in October 2017, deploying across 16 portfolio companies. Fund II is targeting up to $100 million to continue the thesis at a larger scale. The firm co-invests with a broad syndicate that includes the EIC Fund, OurCrowd and Agrinnovation. Notable portfolio companies include SKYX Solutions (now rebranded LahakX), which develops autonomous drone systems for crop protection, Salicrop, whose non-GMO seed treatments enable plants to thrive in high-salinity soils and with brackish-water irrigation, and Sufresca, a post-harvest technology company reported as Rimonim's fourth investment. Rimonim brings deep domain expertise and scientific networks to its portfolio companies, connecting founders with Israel's world-class agricultural research institutions and facilitating commercialization in export markets. The firm's geographic mandate is focused on Israel, where it serves as a specialist anchor investor in the agri-tech and food-tech sectors within one of the world's most productive innovation ecosystems for agricultural technology.

Root Ventures, founded in 2013 and headquartered in San Francisco, is a seed-stage venture capital firm that focuses on investing in deep tech startups. The firm emphasizes supporting technical teams working on groundbreaking innovations across various sectors, including hardware, software, and biotechnology. Root Ventures has a diverse portfolio, with notable investments in companies like Stellar Pizza, a robotics company acquired in 2024; Nautilus Labs, a maritime analytics platform; and TruckLabs, which offers tech-enabled solutions for the trucking industry. Other significant investments include Shaper Tools, a provider of digital tools for the construction industry, and Daily, a video conferencing solution. The firm has made 114 investments and achieved 16 successful exits, demonstrating their ability to identify and nurture promising startups. Root Ventures is led by a team of experienced partners, including founding partner Avidan Ross, Chrissy Meyer, Kane Hsieh, and Lee Edwards. They focus on providing not only capital but also strategic guidance and support to help their portfolio companies succeed.

Robert Bosch Venture Capital GmbH (RBVC), founded in 2007, is the corporate venture capital arm of the Bosch Group. Based in Stuttgart-Weilimdorf, Germany, RBVC focuses on investing in innovative technology startups globally, covering early to late-stage investments. Their investment strategy spans multiple sectors, including automation, electrification, mobility solutions, healthcare, energy efficiency, artificial intelligence (AI), Internet of Things (IoT), and advanced computing technologies. RBVC has a diversified portfolio with notable investments in companies such as Aleph Alpha, an AI startup, and AnyClip, a multimedia and design software company. They have also invested in startups like Graphcore, which develops intelligent processing units for AI workloads, and IOTA, which focuses on blockchain-based M2M payments​. The firm typically invests between €3-5 million in initial financing rounds, with the potential to invest up to €15 million in total per company. Additionally, RBVC selectively provides seed capital and participates in other venture capital funds to build a robust international and industrial network​. RBVC's investments have led to several successful exits, including the acquisitions of companies like Foghorn by Johnson Controls and GreenPeak by Qorvo. They are known for leveraging Bosch's extensive network to help startups scale and establish new business models, often fostering co-innovation through the Open Bosch Program.

Robust VC is an early-stage venture capital firm established in 2022 with headquarters in San Francisco. The firm takes an industry-agnostic approach to investment, focusing on identifying and backing startups with the potential to drive significant technological advancements. With a global reach, Robust VC actively seeks opportunities in the U.S., Southeast Asia, and regions such as Singapore, Thailand, Indonesia, and the Philippines​. Led by founder Kanin Asva, who has a diverse background in investment and risk management, the firm prides itself on delivering precise, high-quality investments rather than taking a "spray-and-pray" approach. Its investments generally range from $25,000 to $1 million, targeting companies at the prototype or early-revenue stages. Robust focuses on fostering innovation and supporting businesses that tackle complex economic, logistical, and technological challenges, particularly in sectors that promise long-term societal and financial returns​. Noteworthy investments include Symbiome, a microbiome-focused skincare brand committed to sustainability, and Offsight, a project management software company improving productivity in modular construction​. The firm’s goal is to partner with transformational companies that offer breakthrough solutions in their industries, helping them scale effectively through hands-on guidance, operational support, and access to a wide network of industry veterans​. Asva's leadership is reflected in his commitment to quality and careful selection of partners, ensuring that Robust's portfolio generates both impactful outcomes and significant financial returns.

ROCH Ventures is a Paris-based venture capital firm founded in 2022 and focused exclusively on travel and hospitality technology startups, primarily at the Series A stage across Europe and Israel. The firm is currently deploying through ROCH Ventures Tech Travel & Hospitality Fund I, targeting approximately EUR 100 million in total investments. ROCH leads rounds and was co-founded by Bobby Demri, a serial entrepreneur who sold his company to Boston Consulting Group in 2017, and Ludger Kuebel-Sorger, Senior Partner Emeritus at BCG. The fund is backed by Boston Consulting Group and supported by a board of advisors drawn from Air France, Ennismore and SBE, Six Senses, Starwood, Four Seasons and major financial institutions. ROCH's investment thesis filters deals across five dimensions: desirability (a product 10x better than the next-best alternative), marketability (validated product-market fit and GTM model), defensibility (unique IP or corporate asset), scalability (total addressable market above $5 billion) and timeliness (riding a major wave over the next 2-3 years). The team reports more than 60 combined years of investing, strategy and operating experience. Three portfolio companies have been disclosed to date: Apartool, where ROCH co-led a EUR 5.5 million Series A alongside Barlon Capital; Raus, a premium sustainable nature-immersion brand that received an EUR 8.5 million seed round; and WeTrip. Raus, the most recent investment, was announced in November 2023. The combination of BCG backing, an industry-heavyweight advisory board and sector exclusivity gives ROCH portfolio companies exceptional access to global travel and hospitality networks -- from airline partnerships to luxury hotel brands -- that are difficult to replicate outside of a purpose-built specialist fund.

RPV Global is a deep tech venture fund dedicated to early-stage, scientifically intensive ventures. Founded in 2021, RPV focuses on transformative technologies across various sectors, including neuroscience, new energy, advanced materials, and additive manufacturing. Their portfolio includes companies like Sanmai, which is developing neuromodulation treatments for anxiety and depression, and PhotonVault, which enhances energy storage from renewable sources​. RPV's strategy emphasizes rigorous scientific methods and ethical standards, aiming to support projects with significant growth potential. They leverage a team of reputable scientists, serial entrepreneurs, and investment professionals, many of whom have deep ties to leading academic and research institutions. This team includes Arkady Kulik, a seasoned entrepreneur and physicist, and Richard Silberstein, a pioneering neuroscientist​. RPV's unique approach includes a global perspective, connecting scientists with entrepreneurs to drive the next wave of technological advancements. They are particularly focused on disruptive innovations that can significantly impact the well-being of humankind​